The PMHNP is seeing clients at an inpatient substance abuse facility. She is called to assist a 42-year-old patient suspected of benzodiazepine overdose who has not responded to 3 mg of flumazenil (Romazicon) administered intravenously (IV). The most appropriate intervention at this time would be to:

Choice A reason: Administering another 3 mg of flumazenil immediately after a failed response to the initial dose is not recommended due to the risk of precipitating seizures, especially in patients with chronic benzodiazepine use or co-ingestion of pro-convulsant substances. Flumazenil has a narrow therapeutic window and should be titrated cautiously. Choice B reason: Although smaller incremental doses of flumazenil (e.g., 0.2–1 mg) may be used in some protocols, repeated dosing after a cumulative 3 mg without response is generally discouraged. The risk of adverse effects, particularly seizures, increases with higher cumulative doses. Choice C reason: Waiting 20 minutes and administering another 3 mg would exceed the recommended maximum cumulative dose of flumazenil, which is typically 3–5 mg. This approach increases the risk of serious complications and is not supported by clinical guidelines. Choice D reason: If a patient does not respond to a total of 3 mg of flumazenil, further administration is not advised. The lack of response suggests that the cause of altered mental status may not be due to benzodiazepines alone or that the patient has developed tolerance. Supportive care and airway management should be prioritized.